Introduction to GHRPs
Growth Hormone Releasing Peptides (GHRPs) represent a class of synthetic peptides that stimulate growth hormone release through the ghrelin receptor (GHS-R1a). Among these, GHRP-6 and GHRP-2 are the most extensively studied, with distinct characteristics that make each suitable for different research applications.
Understanding the differences between these two peptides helps researchers select the most appropriate compound for their specific needs.
Discovery and Development
GHRP-6 Background
History:
- Among the first GHRPs developed
- Discovered in 1980s
- Extensive research base
- Template for subsequent GHRPs
Structure:
- Hexapeptide (6 amino acids)
- Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
- Contains unnatural amino acids for stability
GHRP-2 Background
History:
- Developed after GHRP-6
- Designed to improve on GHRP-6's profile
- Sometimes called "second generation" GHRP
- Extensive research continues
Structure:
- Hexapeptide (6 amino acids)
- Sequence: D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
- Modified to enhance certain properties
Mechanism Comparison
Shared Mechanism
Both peptides:
- Bind to ghrelin receptor (GHS-R1a)
- Stimulate GH release from pituitary
- Suppress somatostatin
- Synergize with GHRH
- Work independently of GHRH receptor
Key Differences
GHRP-6:
- Higher affinity for GHS-R1a in appetite centers
- More potent ghrelin-like effects
- Stronger peripheral effects
GHRP-2:
- Modified receptor binding profile
- More selective for GH-related effects
- Reduced peripheral ghrelin activity
Growth Hormone Release
Potency Comparison
GH Release Capacity:
| Aspect | GHRP-6 | GHRP-2 |
|---|---|---|
| GH Peak | Very High | Very High |
| Duration | Moderate | Moderate |
| Dose-Response | Clear | Clear |
| Ceiling Effect | Yes | Yes |
Both are highly effective at stimulating GH release, with similar peak levels in most studies.
Timing and Pattern
GHRP-6:
- Rapid onset (~15-30 minutes to peak)
- GH elevation lasts ~2-3 hours
- Clear pulsatile pattern
GHRP-2:
- Similar onset timing
- Comparable duration
- Equivalent pulsatile pattern
With GHRH Synergy
Both peptides synergize with GHRH analogs:
- Combined GH release exceeds individual effects
- Similar synergy magnitude
- See our CJC-1295/Ipamorelin guide for combination discussion
Side Effect Comparison
Appetite Effects
GHRP-6:
- Strong appetite stimulation
- Occurs shortly after administration
- Significant and consistent effect
- Mimics ghrelin's hunger signaling
GHRP-2:
- Moderate appetite increase
- Less intense than GHRP-6
- More manageable for most
- Still present but reduced
Research Implications:
- GHRP-6 may be desirable when appetite stimulation is wanted
- GHRP-2 better when appetite increase is unwanted
- Ipamorelin superior if avoiding appetite effects entirely
Cortisol Effects
GHRP-6:
- Moderate cortisol elevation
- Can be significant at higher doses
- May impact stress-related research
GHRP-2:
- Lower cortisol elevation
- More selective profile
- Less interference with cortisol studies
Prolactin Effects
GHRP-6:
- Moderate prolactin increase
- Similar to cortisol pattern
- Dose-dependent
GHRP-2:
- Lower prolactin elevation
- More favorable profile
- Less concern for most applications
Comparison Table
| Side Effect | GHRP-6 | GHRP-2 | Ipamorelin |
|---|---|---|---|
| Appetite | High | Moderate | Minimal |
| Cortisol | Moderate | Low-Moderate | Minimal |
| Prolactin | Moderate | Low-Moderate | Minimal |
| Water Retention | Moderate | Moderate | Low |
| Head Rush | Sometimes | Sometimes | Rarely |
Application Comparison
When GHRP-6 May Be Preferred
Research Contexts:
- Appetite stimulation is desired
- Studying ghrelin system effects
- Caloric intake needs increasing
- Cachexia or wasting research
Practical Considerations:
- Generally less expensive
- More widely available
- Extensive research base
When GHRP-2 May Be Preferred
Research Contexts:
- GH-focused research with minimal confounders
- When appetite increase is problematic
- Studies requiring cleaner hormone profile
- When cortisol/prolactin effects are concerns
Practical Considerations:
- Better side effect profile overall
- More selective GH stimulation
- Good balance of potency and tolerability
When Neither May Be Best
Consider Ipamorelin When:
- Minimal side effects needed
- Highly selective GH stimulation required
- Long-term protocols planned
- Women or sensitive populations
See our secretagogues overview for comprehensive comparison.
Protocol Considerations
Dosing Ranges
GHRP-6 Research Ranges:
- Low: 50-100 mcg
- Moderate: 100-200 mcg
- High: 200-300 mcg
- Per administration, typically 2-3x daily
GHRP-2 Research Ranges:
- Similar to GHRP-6
- Often slightly lower doses achieve equivalent GH release
- Individual response varies
Timing
Both peptides follow similar timing principles:
- Administered on empty stomach
- 2-3 hours after eating
- 30-60 minutes before food
- Pre-bed dosing aligns with natural GH peak
See our timing guide.
Stacking
With GHRH Analogs:
- Both synergize with CJC-1295
- Combination preferred for maximal GH release
- GHRH + GHRP is standard approach
Protocol Example:
- CJC-1295 (100-200 mcg) + GHRP-2 (100-200 mcg)
- Or CJC-1295 + GHRP-6 (same ranges)
- 2-3 times daily, fasted
Reconstitution and Handling
Standard Protocol
Both peptides require:
- Bacteriostatic water for reconstitution
- Gentle mixing (no shaking)
- Refrigeration after reconstitution
- Sterile technique throughout
See our reconstitution guide.
Stability
Lyophilized (Powder):
- Both stable in freezer for extended periods
- Refrigerator for shorter storage
- Protect from light
Reconstituted:
- Refrigerate (2-8°C)
- Use within 4-6 weeks typically
- Never freeze reconstituted solution
See our storage guide.
Quality Considerations
Sourcing Importance
As research compounds, quality varies:
- Purity affects results
- Impurities can cause reactions
- Proper identification essential
Verification
Look for:
- Third-party COAs
- HPLC purity data (>98%)
- Mass spectrometry confirmation
- Reputable supplier track record
See our supplier guide.
Safety Considerations
General Safety
Both peptides have been studied extensively:
- Relatively well-tolerated in research
- Short-term safety data available
- Long-term data limited
- Individual response varies
Specific Concerns
GHRP-6:
- Appetite effects can be problematic
- Cortisol elevation may matter for some research
- Prolactin elevation in some contexts
GHRP-2:
- Generally fewer concerns
- Still has some hormone effects beyond GH
- Individual sensitivity varies
When to Avoid
Both peptides may not be appropriate:
- Active cancer (theoretical concerns)
- Diabetic retinopathy
- Certain cardiac conditions
- Pregnancy/nursing
Comparison Summary
Side-by-Side
| Factor | GHRP-6 | GHRP-2 |
|---|---|---|
| GH Release | Very Strong | Very Strong |
| Appetite Stimulation | High | Moderate |
| Cortisol Elevation | Moderate | Low-Moderate |
| Prolactin Elevation | Moderate | Low-Moderate |
| Overall Selectivity | Lower | Higher |
| Research Base | Extensive | Extensive |
| Cost | Generally Lower | Moderate |
| Best For | Appetite + GH | GH with fewer sides |
Making the Choice
Choose GHRP-6 if:
- Appetite stimulation beneficial
- Cost is primary concern
- Studying broad ghrelin effects
Choose GHRP-2 if:
- Cleaner hormone profile needed
- Appetite stimulation unwanted
- Better tolerability important
Choose Ipamorelin if:
- Minimal side effects critical
- Most selective GH release needed
- Long-term protocols planned
Conclusion
GHRP-6 and GHRP-2 are both effective GH secretagogues with distinct profiles. GHRP-6's stronger appetite stimulation and broader ghrelin effects make it suitable when those properties are desired. GHRP-2's more selective profile offers a better-tolerated option when focused GH stimulation is the primary goal.
For most GH-focused research, GHRP-2 or Ipamorelin offer favorable profiles, while GHRP-6 remains valuable when appetite stimulation or broader ghrelin effects are relevant.
Related Resources: